Martin Wilson joins Rocket Pharmaceutical as general counsel & CCO

Rocket Pharmaceuticals, a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, has appointed Martin Wilson (pictured) as general counsel, chief compliance officer and senior vice president. Wilson will be oversee the Legal and Compliance functions and serve as a key member of the leadership team.

Wilson brings nearly 20 years of legal, compliance and executive experience and accomplishment within the life sciences industry. He most recently served as general counsel and chief corporate officer at Ichnos Sciences, where oversaw legal, compliance, business development, human resources and IT. Wilson served as general counsel, chief compliance officer, corporate secretary and head of human resources at Teligent. Prior to that, he was vice president and assistant general counsel at Endo Pharmaceuticals following the acquisition of Par Pharmaceuticals. Wilson also held multiple roles of increasing responsibility during his 11 year tenure at Par, including chief compliance officer.

Martin Wilson joins Rocket Pharmaceutical as general counsel & CCO


is the international magazine, in English, that covers legal and inhouse affairs in the United States, through experiences beyond Italy’s borders to reach overseas destinations and all over the world.

For more information, visit the Group’s website

LC srl – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 10.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram